Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer
- 513 Downloads
Ovarian cancer is associated with high mortality due to asymptomatic nature of the disease and advance stage at presentation. In advanced stages, it is associated with cachexia and ascites leading to malnutrition. Nutritional status of a patient with cancer has been well known to be associated with survival and can be assessed by level of albumin in blood. Therefore, in this study, we sought to determine preoperative serum albumin as prognostic predictor of survival in patients with ovarian cancer. Preoperative serum albumin was determined in 235 patients undergoing surgery for ovarian cancer at Royal Derby Hospital. The prognostic predictive value of serum albumin, along with other prognostic markers was then analysed using univariate and multivariate analyses. Low serum albumin was associated with poor survival (P < 0.001) in patients with ovarian cancer. There was an inverse correlation between serum albumin levels and survival with lower levels having poor survival. Patients with serum albumin levels of <25 g/l had a median survival of 4.8 months (95% CI 0–13.1 months), whilst levels >35 g/l were associated with median survival of 43.2 months (95% CI 11.6–20.9). Serum albumin (P < 0.001) retained its significance as an independent predictor of poor survival on Cox’s multivariate regression analysis along with Age (P < 0.001) and FIGO stage (P < 0.001). Serum albumin can be used as an independent prognostic predictor of survival in patients with ovarian cancer.
KeywordsPreoperative serum albumin Prognostic predictor Ovarian cancer
Conflict of interest
- 1.Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM. GLOBCAN. Available from: http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900#WOMEN (2008).
- 2.SEER. Available from: www.cancer.gov/cancertopics/types/ovarian (2010).
- 3.Cancer Research UK Ovarian Cancer incidence statistics. Cancer Research, UK. Available from: http://info.cancerresearchuk.org/cancerstats/types/ovary/incidence/index.htm (2007).
- 7.Ottery FD.Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol. 1995;22(2 Suppl 3):98–111.Google Scholar
- 8.Burtis CA. A.E.T., textbook of clinical chemistry. Philadelphia: WB Saunders Company; 1999.Google Scholar
- 14.Gadducci A et al. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management. Anticancer Res. 2001;21(4B):2941–2947.Google Scholar
- 15.Garcia-Luna PP, Parejo Campos J, Pereira Cunill JL. Causes and impact of hyponutrition and cachexia in the oncologic patient. Nutr Hosp. 2006;21 (Suppl 3):10–16.Google Scholar